C07D 499/14
Preparation of salts
C07D499/14 (Preparation of salts) appears on 9 US grants and 9 published applications in this corpus.
Search patents in C07D- Granted patents
- 9
- Published applications
- 9
- Assignees
- 4
- Inventors
- 11
- Latest grant
- 1 Apr 2014
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 2 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 0 |
| 2010 | 0 | 3 |
| 2011 | 0 | 0 |
| 2012 | 2 | 1 |
| 2013 | 2 | 0 |
| 2014 | 1 | 2 |
| 2015 | 0 | 1 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Tazobactam arginine compositions1 Apr 2014US 8,685,957 B1Cubist Pharmaceuticals, Inc.
- L-Threonine derivatives of high therapeutic index22 Oct 2013US 8,563,776 B2Signature R&D Holdings, LLC
- Tazobactam arginine compositions2 Jul 2013US 8,476,425 B1Cubist Pharmaceuticals, Inc.
- L-threonine derivatives of high therapeutic index29 May 2012US 8,188,311 B2Signature R&D Holdings, LLC
- Compounds with high therapeutic index8 May 2012US 8,173,840 B2Signature R&D Holdings, LLC
- Tazobactam Arginine Compositions12 Mar 2015US 2015/0072957 A1Calixa Therapeutics, Inc.
- Tazobactam Arginine Compositions14 Aug 2014US 2014/0228337 A1Cubist Pharmaceuticals, Inc.
- Tazobactam arginine compositions27 Mar 2014US 2014/0088067 A1Cubist Pharmaceuticals, Inc.
- Novel compounds with high therapeutic index15 Nov 2012US 2012/0289471 A1Signature R&D Holdings, LLC
- L-threonine derivatives of high therapeutic index18 Mar 2010US 2010/0069446 A1Signature R&D Holdings, LLC
Most cited
By later US patents
- L-Threonine derivatives of high therapeutic index33US 7,589,233 B2Signature R&D Holdings, LLC · 2009
- Compounds with high therapeutic index23US 8,173,840 B2Signature R&D Holdings, LLC · 2012
- Tazobactam arginine compositions11US 8,476,425 B1Cubist Pharmaceuticals, Inc. · 2013
- Topoisomerase II inhibitors and therapeutic uses therefor9US 5,622,960 AThe United States of America as represented by the Department of Health and Human Services · 1997
- Tazobactam arginine compositions5US 8,685,957 B1Cubist Pharmaceuticals, Inc. · 2014